Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for central nervous system (CNS) conditions. The company leverages a multi-mechanistic approach and the 505(b)(2) regulatory pathway to address significant unmet medical needs in areas such as depression, Alzheimer's disease, and narcolepsy.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
10Traction
0Team
30Visibility
2Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Axsome Therapeutics do?
Axsome Therapeutics is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for central nervous system (CNS) conditions. The company leverages a multi-mechanistic approach and the 505(b)(2) regulatory pathway to address significant unmet medical needs in areas such as depression, Alzheimer's disease, and narcolepsy.
Where is Axsome Therapeutics headquartered?
Axsome Therapeutics is headquartered in New York, United States.
When was Axsome Therapeutics founded?
Axsome Therapeutics was founded in 2012.
What industry does Axsome Therapeutics operate in?
Axsome Therapeutics operates in Biotech, Pharmaceuticals, Healthcare.
What is Axsome Therapeutics's current status?
Axsome Therapeutics's current operating status is: Public.
Similar Startups